Recent advances in the field of endoscopy have found fertile ground for application in inflammatory bowel diseases (IBD). Mucosal healing is a primary goal of IBD therapy, and current evidence shows that histologic remission (HR) is an additional desirable outcome. However, with the use of standard endoscopy, a considerable number of patients with histologically active disease go unrecognized. This narrative article examines the role, current or potential, of each endoscopic technique, from standard white-light endoscopy to molecular imaging, in the assessment of mucosal healing and HR in IBD.
Keywords: Artificial intelligence; Chromoendoscopy; Confocal laser endomicroscopy; Endocytoscopy; Inflammatory bowel diseases; Molecular imaging.
Copyright © 2024 Elsevier Inc. All rights reserved.